10 Credits SPRING

Co-requisites: MED6020, MED6021, MED6023, MED6024

Aims/Description: This module covers the science, economics and the ethical and current legal framework for preclinical development and clinical trials. The unit is based on worked examples. We discuss the practice of preclinical development of conventional small molecule drugs and recombinant agents, the ethics, governance and the structure of clinical trials and the interpretation of trial results. Lectures will be followed by tutorial-style demonstrations of key research methods and a problem-based learning module focusing on how new therapies for a specific disease condition have been identified and tested by research teams within the School.

Teaching Methods: Lectures, Tutorials, Problem solving, Independent Study
Assessment: Course work

Information on the department responsible for this unit (Infection, Immunity and Cardiovascular Disease):

Teaching timetable


The content of our courses is reviewed annually to make sure it's up-to-date and relevant. Individual modules are occasionally updated or withdrawn. This is in response to discoveries through our world-leading research; funding changes; professional accreditation requirements; student or employer feedback; outcomes of reviews; and variations in staff or student numbers. In the event of any change we'll consult and inform students in good time and take reasonable steps to minimise disruption.

URLs used in these pages are subject to year-on-year change. For this reason we recommend that you do not bookmark these pages or set them as favourites.

Teaching methods and assessment displayed on this page are indicative for 2021-22. Students will be informed by the academic department of any changes made necessary by the ongoing pandemic.

Western Bank, Sheffield, S10 2TN, UK